Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FX7Y5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,116
Award facts
- Contract value 100% obligated
- $12,115.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 10 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this firm fixed-price delivery order with an ultimate completion date of September 10, 2025. The award was made without a set-aside designation, reflecting the vendor's competitive standing in federal procurement markets. Performance will occur at the vendor's facility in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.99 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive portfolio of pharmaceutical products supporting military health facilities worldwide. As a primary supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group supplies branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. Jakafi (ruxolitinib) is a prescription medication used to treat myelofibrosis and other blood disorders, representing the type of specialized pharmaceutical products the vendor routinely delivers to support military medical operations.
Quick answers
Who was awarded contract SPE2DB25FX7Y5?
SPE2DB25FX7Y5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FX7Y5 worth?
The government has obligated $12,116 on SPE2DB25FX7Y5.
Is contract SPE2DB25FX7Y5 an order under another contract?
Yes. SPE2DB25FX7Y5 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.
Was contract SPE2DB25FX7Y5 competed?
The extent of competition for SPE2DB25FX7Y5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award